Rui Jing Jiang, Avisi Technologies - Nanotechnology-Enabled Implant | LSI USA '24

Avisi is developing a portfolio of ophthalmic treatments based on a novel metamaterial technology.

LSI Europe ‘24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

September 16-20, 2024 The Ritz-Carlton - Sintra, Portugal Register arrow